Genetics of Mortality in Critical Care GenOMICC is a, open, collaborative, global community of doctors and scientists trying to understand and treat critical illness.
Our partners have been recruiting patients since 2016 to study emerging infections (SARS/MERS/Flu), sepsis, and other forms of critical illness. It is the largest study of its kind anywhere in the world.
Susceptibility to COVID-19 is almost certainly, in part, genetic. GenOMICC can find the genes that cause susceptibility, which may help us to prioritise treatments to respond to the global crisis. All patients with confirmed COVID-19 in critical care are eligible for GenOMICC.
Further information can be found at: https://genomicc.org/